Steven S. Gallinger

Steven S. Gallinger's AcademicInfluence.com Rankings

Steven S. Gallinger

Philosophy

#5658

World Rank

#8525

Historical Rank

Logic

#2900

World Rank

#3972

Historical Rank

philosophy Degrees

Steven S. Gallinger

Biology

#7622

World Rank

#10572

Historical Rank

Molecular Biology

#893

World Rank

#916

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Steven S. Gallinger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Steven S. Gallinger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice (2007) (4169)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. (2007) (3726)
International network of cancer genome projects (2010) (1839)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes (2012) (1752)
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. (2000) (1304)
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. (2010) (1235)
MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma (1996) (900)
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. (2005) (571)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. (2018) (538)
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids (2015) (521)
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. (2015) (506)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes (2018) (500)
Self-renewal as a therapeutic target in human colorectal cancer (2013) (446)
EphB receptor activity suppresses colorectal cancer progression (2005) (423)
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. (2007) (413)
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns (2016) (399)
MSH2 deficient mice are viable and susceptible to lymphoid tumours (1995) (394)
Telomerase activity associated with acquisition of malignancy in human colorectal cancer. (1995) (378)
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria (2004) (374)
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. (2007) (355)
Genotype-phenotype correlations in attenuated adenomatous polyposis coli. (1998) (347)
Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. (2004) (331)
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial (2017) (327)
Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. (1994) (322)
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers (2014) (314)
Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. (2000) (300)
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. (2015) (296)
Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers (2015) (295)
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. (1999) (273)
Distinguishing right from left colon by the pattern of gene expression. (2003) (270)
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. (1999) (259)
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution (2020) (258)
Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. (2006) (252)
Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. (2015) (251)
Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. (2000) (239)
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients (1997) (233)
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. (2000) (224)
Activation of Notch signaling in human colon adenocarcinoma. (2008) (219)
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. (2006) (217)
An Aggressive Surgical Approach Leads to Improved Survival in Patients With Gallbladder Cancer: A 12-Year Study at a North American Center (2005) (215)
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma (2017) (205)
ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. (2012) (204)
MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. (2005) (198)
Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. (1996) (187)
MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. (1996) (185)
Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. (2004) (183)
Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. (2014) (182)
Problems of Delivery of Monoclonal Antibodies (1995) (180)
Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management (2005) (178)
Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. (2007) (172)
Changing causes of mortality in patients with familial adenomatous polyposis (1996) (164)
Lymph Node Retrieval and Assessment in Stage II Colorectal Cancer: A Population-Based Study (2003) (162)
K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. (1993) (161)
Risk factors in elective laparoscopic cholecystectomy for conversion to open cholecystectomy. (1994) (157)
Needle tract seeding after radiofrequency ablation of hepatic tumors. (2005) (150)
Diagnosis and management of pancreatic cancer (2013) (149)
Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. (2014) (147)
Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. (2009) (144)
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. (1999) (142)
Survival After Hepatic Resection for Colorectal Metastases: A 10-Year Experience (2006) (142)
Molecular biology of colorectal cancer. (1997) (139)
Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial (1999) (135)
Effect of mucous glycoprotein on nucleation time of human bile. (1985) (134)
Screening for Pancreatic Cancer in a High-Risk Cohort: An Eight-Year Experience (2012) (129)
Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. (2004) (129)
CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma – a quantitative analysis (2017) (124)
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer (2020) (120)
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. (2019) (118)
Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? (2002) (117)
Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. (1999) (116)
Resection of hepatocellular carcinoma without preoperative tumor biopsy. (2001) (113)
Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. (2006) (112)
Survival after liver resection for metastatic colorectal carcinoma in a large population. (2007) (112)
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ (2000) (109)
A cyclophilin-related protein involved in the function of natural killer cells. (1993) (109)
Motivations and psychosocial impact of genetic testing for HNPCC. (2001) (105)
Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing (2014) (103)
Waking up the next morning: surgeons’ emotional reactions to adverse events (2012) (101)
Biliary proteins and the nucleation defect in cholesterol cholelithiasis. (1987) (100)
Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. (1994) (100)
The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. (2012) (100)
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer (1999) (99)
Characterization of mutant MUTYH proteins associated with familial colorectal cancer. (2008) (97)
Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. (2013) (96)
Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. (1999) (96)
Relatives of colorectal cancer patients: factors associated with screening behavior. (2003) (96)
The Histomorphology of Lynch Syndrome–associated Ovarian Carcinomas: Toward a Subtype-specific Screening Strategy (2014) (96)
Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. (2006) (94)
Bile duct injuries associated with laparoscopic cholecystectomy: timing of repair and long-term outcomes. (2010) (94)
Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis (2001) (93)
High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. (1994) (92)
Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma (2005) (91)
The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. (1996) (90)
Spatially confined sub-tumor microenvironments in pancreatic cancer (2021) (89)
An Analysis of Resection vs Transplantation for Early Hepatocellular Carcinoma: Defining the Optimal Therapy at a Single Institution (2007) (89)
The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease (2010) (87)
Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. (2015) (87)
Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer (2019) (86)
NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma (2019) (86)
Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis (2011) (85)
Prognosis and Results After Resection of Very Large (≥10 cm) Hepatocellular Carcinoma (2007) (85)
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. (2011) (83)
MLH1 –93G>A Promoter Polymorphism and the Risk of Microsatellite-Unstable Colorectal Cancer (2007) (82)
MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. (2007) (82)
Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome. (2008) (82)
Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. (1998) (81)
Chemotherapy-induced Liver Injury in Metastatic Colorectal Cancer: Semiquantitative Histologic Analysis of 334 Resected Liver Specimens Shows That Vascular Injury but not Steatohepatitis Is Associated With Preoperative Chemotherapy (2010) (80)
Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes (2016) (80)
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study. (2017) (80)
Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation‐positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries (2012) (79)
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG). (2010) (79)
α2HS-glycoprotein, an Antagonist of Transforming Growth Factor β In vivo, Inhibits Intestinal Tumor Progression (2004) (78)
A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age (2014) (77)
Colorectal cancer survivors undergoing genetic testing for hereditary non‐polyposis colorectal cancer: motivational factors and psychosocial functioning (2007) (73)
Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas (2002) (71)
Endoscopic or percutaneous biliary drainage for Klatskin tumors? (2013) (69)
High protein and total lipid concentration are associated with reduced metastability of bile in an early stage of cholesterol gallstone formation. (1990) (68)
Chemotherapy for desmoid tumors in association with familial adenomatous polyposis (1997) (68)
Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. (2006) (68)
Recurrent Pyogenic Cholangitis with Hepatolithiasis—The Role of Surgical Therapy in North America (2008) (68)
The Gastrointestinal Phenotype of Germline Biallelic Mismatch Repair Gene Mutations (2010) (68)
Does intraoperative hepatic ultrasonography change surgical decision making during liver resection? (1994) (66)
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. (2022) (66)
Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. (2011) (65)
Somatic instability of the APC I1307K allele in colorectal neoplasia. (1998) (65)
Germline BRCA1 mutations predispose to pancreatic adenocarcinoma (2008) (64)
High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes (2005) (63)
BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts (2015) (63)
Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow‐up of a kindred (2012) (62)
Neuroendocrine Tumors of the Gastrointestinal Tract: A Decade of Experience at the Princess Margaret Hospital (2008) (62)
Early laparoscopic cholecystectomy for acute cholecystitis: A safe procedure (1999) (62)
Tumor microsatellite instability in early onset gastric cancer. (2005) (61)
Does early colectomy increase desmoid risk in familial adenomatous polyposis? (2007) (60)
A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer (2020) (60)
Liver resection for colorectal cancer metastases. (2013) (60)
Vitamin D Intake Is Negatively Associated with Promoter Methylation of the Wnt Antagonist Gene DKK1 in a Large Group of Colorectal Cancer Patients (2012) (59)
Microsatellite Instability as a Prognostic Factor in Resected Colorectal Cancer Liver Metastases (2004) (59)
Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma (2004) (59)
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri‐operative outcomes (2007) (59)
PMS2 monoallelic mutation carriers: the known unknown (2015) (58)
STK11/LKB1 germline mutations are not identified in most Peutz–Jeghers syndrome patients (1999) (57)
Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome (2019) (57)
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. (2001) (57)
Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario (2009) (57)
Improved Long-Term Outcomes After Resection of Pancreatic Adenocarcinoma: A Comparison Between Two Time Periods (2015) (57)
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer (2017) (57)
Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites. (2002) (56)
Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma (2013) (56)
Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole (2015) (56)
APC mutation and the crypt cycle in murine and human intestine. (1997) (55)
Pancreatic Resection for Metastatic Renal Cell Carcinoma: Presentation, Treatment, and Outcome (2003) (55)
Microsatellite instability, mismatch repair deficiency, and colorectal cancer. (2001) (55)
Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones. (1986) (55)
In situ hypothermic liver preservation during radical liver resection with major vascular reconstruction (2009) (55)
A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. (1995) (55)
Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors (2001) (55)
Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: a critical review of the literature. (1997) (54)
Chemotherapy of MMR-deficient colorectal cancer (2013) (54)
Familial adenomatous polyposis. (2000) (54)
Clinical and economic comparison of laparoscopic to open liver resections using a 2-to-1 matched pair analysis: an institutional experience. (2012) (53)
Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. (2006) (53)
Sulindac for periampullary polyps in FAP patients (1997) (53)
Hepatic resection of noncolorectal nonneuroendocrine metastases (2000) (53)
Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. (1996) (53)
Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome (2009) (52)
Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma (2019) (52)
Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. (2005) (52)
Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning (2010) (51)
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. (2021) (51)
Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients. (1993) (51)
Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma (2017) (51)
alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression. (2004) (50)
Up-front Hepatic Resection for Metastatic Colorectal Cancer Results in Favorable Long-term Survival (2013) (50)
Molecular Events in the Natural History of Pancreatic Cancer. (2017) (49)
CDH1/E-cadherin germline mutations in early-onset gastric cancer (2006) (49)
Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation (2012) (49)
A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis. (1996) (49)
Role of Magnetic Resonance Cholangiography in Assessing Biliary Anatomy in Right Lobe Living Donors (2005) (48)
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma (2000) (48)
Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis (1999) (48)
Vesicular cholesterol in bile. Relationship to protein concentration and nucleation time. (1988) (47)
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer (2017) (47)
Laparoscopic versus open liver resection for hepatocellular carcinoma at a North-American Centre: a 2-to-1 matched pair analysis. (2015) (47)
Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer. (2016) (47)
The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer (2007) (47)
Hypoxia Provokes Base Excision Repair Changes and a Repair-Deficient, Mutator Phenotype in Colorectal Cancer Cells (2014) (46)
Interpreting three-dimensional structures from two-dimensional images: a web-based interactive 3D teaching model of surgical liver anatomy. (2009) (46)
Heterozygosity for the BLMAsh Mutation and Cancer Risk (2003) (46)
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma (2020) (44)
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study. (2007) (44)
Giant leiomyoma of the esophagus. (1983) (43)
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients. (1995) (43)
Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer (2014) (43)
Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. (1992) (43)
Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis (2004) (42)
The APC I1307K allele and breast cancer risk (1998) (41)
Mutations of the MYH gene do not substantially contribute to the risk of breast cancer (2009) (41)
CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging (2019) (41)
Predictors of peri-opertative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease. (2011) (40)
Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. (2006) (40)
Germline MYH mutations in a clinic‐based series of Canadian multiple colorectal adenoma patients (2007) (40)
Heterozygosity for the BLM(Ash) mutation and cancer risk. (2003) (40)
Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants (2013) (40)
Specific Variants in the MLH1 Gene Region May Drive DNA Methylation, Loss of Protein Expression, and MSI-H Colorectal Cancer (2010) (40)
Chemotherapy for desmoid tumours in association with familial adenomatous polyposis: a report of three cases. (1996) (40)
Outcome of Adjuvant Therapy in Biliary Tract Cancers (2015) (39)
Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance. (1998) (38)
Differential gene expression profile reveals deregulation of pregnancy specific β1 glycoprotein 9 early during colorectal carcinogenesis (2005) (38)
Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome (2011) (37)
Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium (2016) (37)
Exome-Wide Association Study of Pancreatic Cancer Risk. (2017) (37)
Celecoxib Treatment Alters the Gene Expression Profile of Normal Colonic Mucosa (2006) (37)
Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients (2011) (37)
Pathological features of colorectal carcinomas in MYH‐associated polyposis (2008) (37)
Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer. (2017) (37)
The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases (2018) (36)
Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior (2013) (35)
Natural history of aberrant crypt foci (1996) (35)
“First, Do No Harm”: Balancing Competing Priorities in Surgical Practice (2012) (34)
Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer (2009) (34)
The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. (2003) (34)
Risk factors associated with recurrence in patients with solid pseudopapillary tumors of the pancreas. (2014) (33)
The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients (2001) (33)
Aberrant right hepatic artery in pancreaticoduodenectomy for adenocarcinoma: impact on resectability and postoperative outcomes. (2014) (33)
Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry (2007) (33)
Impact of Regional Lymph Node Evaluation in Staging Patients With Periampullary Tumors (2006) (32)
Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer (2013) (32)
Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. (1993) (32)
Liver transplantation for acute and subacute fulminant hepatic failure. (1989) (32)
Moderators of cancer‐related distress and worry after a pancreatic cancer genetic counseling and screening intervention (2012) (32)
Transduodenal Resection of Peri-Ampullary Lesions (2005) (31)
Combined burden and functional impact tests for cancer driver discovery using DriverPower (2020) (31)
Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. (2009) (31)
Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients. (1997) (31)
Long-Term Effect of Aspirin on Colorectal Cancer Incidence and Mortality : 20-Year Follow-Up of Five Randomized Trials (2012) (30)
Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi process. (2009) (29)
Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent (2018) (27)
Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases (2019) (27)
Increased Cancer Predisposition in Family Members of Colorectal Cancer Patients Harboring the p.V600E BRAF Mutation: a Population-Based Study (2010) (27)
Natural history of aberrant crypt foci. A surgical approach. (1996) (27)
Use of Mismatch Repair Immunohistochemistry and Microsatellite Instability Testing: Exploring Canadian Practices (2012) (27)
Café‐au‐lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2 (2008) (27)
Identification of germline genomic copy number variation in familial pancreatic cancer (2012) (27)
Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma (2013) (26)
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer. (2007) (26)
Hereditary Pancreatic Cancer Syndromes. (2015) (26)
Predictors of Multivisceral Resection in Patients with Locally Advanced Colorectal Cancer (2008) (26)
Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing (2014) (26)
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. (2020) (26)
Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases (2016) (26)
Proximal bile duct cancer. (1990) (25)
Management of advanced duodenal polyposis in familial adenomatous polyposis (1997) (25)
Comparison of cellular immunotherapies and anti-CD3 in the treatment of MCA-38-LD experimental hepatic metastases in C57BL/6 mice. (1990) (25)
Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry (2017) (25)
Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer (2006) (25)
Local hepatic tuberculosis, the cause of a painful hepatic mass: case report and review of the literature. (1986) (25)
Water-jet dissection for parenchymal division during hepatectomy. (2006) (24)
Duodenal adenomas in familial adenomatous polyposis: relation of cell differentiation and mucin histochemical features to growth pattern. (1994) (24)
Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue. (2019) (24)
Blood oxygen level‐dependent liver MRI: Can It predict microvascular invasion in HCC? (2013) (24)
Cancer of the gallbladder and extrahepatic bile ducts. (2007) (23)
MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study. (2010) (23)
Long‐term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome (2015) (23)
Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases. (2014) (23)
Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. (2010) (22)
Identification of somatic APC gene mutations in periampullary adenomas in a patient with familial adenomatous polyposis (FAP). (1993) (22)
Pancreatic cancer ascites xenograft–an expeditious model mirroring advanced therapeutic resistant disease (2017) (22)
The APCI1307K allele and breast cancer risk. (1998) (22)
Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images (2019) (22)
Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673. (2015) (22)
A clinical‐radiomic model for improved prognostication of surgical candidates with colorectal liver metastases (2019) (22)
Msh2 deficiency enhances somatic Apc and p53 mutations in Apc+/-Msh2-/- mice. (2003) (21)
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada (2018) (21)
How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry (2014) (21)
Intestinal knockout of Nedd4 enhances growth of Apcmin tumors (2016) (21)
EphB receptor activity suppresses colorectal cancer progression (vol 435, pg 1126, 2005) (2005) (20)
Quality of Life in Adults Diagnosed With Familial Adenomatous Polyposis and Desmoid Tumor (2004) (20)
Progression and Management of Duodenal Neoplasia in Familial Adenomatous Polyposis: A Cohort Study. (2015) (20)
Effect of binding of ionised calcium on the in vitro nucleation of cholesterol and calcium bilirubinate in human gall bladder bile. (1986) (20)
A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases (2005) (20)
Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas. (2019) (20)
Practice Patterns for the Management of Hepatic Metastases from Colorectal Cancer: A Mixed Methods Analysis (2013) (19)
Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases (2019) (19)
Missense Polymorphisms in the Adenomatous Polyposis Coli Gene and Colorectal Cancer Risk (2008) (19)
Taking a Chance or Playing It Safe: Reframing Risk Assessment Within the Surgeon's Comfort Zone. (2015) (18)
Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today? (1996) (18)
Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1. (1994) (18)
Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases (2022) (17)
Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries. (2018) (17)
Management of pancreatic adenocarcinoma in Ontario, Canada: a population-based study using novel case ascertainment. (2011) (17)
The impact of a clinical pathway on patient postoperative recovery following pancreaticoduodenectomy. (2017) (17)
Expression of the NK-TR gene is required for NK-like activity in human T cells. (1994) (17)
Oncologic surveillance for subjects with biallelic mismatch repair gene mutations-10 year follow-up in a kindred (2011) (17)
Mutations in Mitochondrial DNA From Pancreatic Ductal Adenocarcinomas Associate With Survival Times of Patients and Accumulate as Tumors Progress. (2018) (17)
Serous Cystadenomas of the Pancreas: Long-term Follow-up Measurement of Growth Rate (2011) (17)
DNA Mismatch Repair Status Predicts Need for Future Colorectal Surgery for Metachronous Neoplasms in Young Individuals Undergoing Colorectal Cancer Resection (2015) (17)
Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy (2016) (17)
Percutaneous Ethanol Injection of Unresectable Medium-to-Large-Sized Hepatomas Using a Multipronged Needle: Efficacy and Safety (2007) (17)
Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan. (2017) (17)
BRM polymorphisms, pancreatic cancer risk and survival (2016) (16)
Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different? (2021) (16)
Germline PMS2 mutations: one hit or two? (2005) (16)
Recapitulating the clinical scenario of BRCA‐associated pancreatic cancer in pre‐clinical models (2018) (16)
Development and validation of an instrument to measure the impact of genetic testing on self‐concept in Lynch syndrome (2011) (16)
Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse. (2000) (16)
The FAP self-concept scale (adult form) (2008) (16)
An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM). (2011) (16)
Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine. (1999) (15)
Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study (2011) (15)
Radiofrequency ablation of malignant hepatic neoplasms. (2002) (15)
Acalculous cholecystitis associated with cytomegalovirus and sclerosing cholangitis in a patient with acquired immunodeficiency syndrome. (1993) (15)
Hepatic adenomas caused by somatic HNF1A mutations in children with biallelic mismatch repair gene mutations. (2011) (14)
A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer (2020) (14)
Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer (2021) (14)
A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases. (2019) (14)
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics (2020) (14)
Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancer. (2014) (14)
Efficient generation of respiratory syncytial virus (RSV)‐neutralizing human MoAbs via human peripheral blood lymphocyte (hu‐PBL)‐SCID mice and scFv phage display libraries (2000) (14)
Combined pancreaticoduodenectomy and colon resection for locally advanced peri-ampullary tumours: analysis of peri-operative morbidity and mortality. (2014) (13)
Genetic testing for Lynch syndrome in the province of Ontario (2016) (12)
Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec. (2015) (12)
Benefits of platinum-based chemotherapy (Pt-chemo) in pancreatic adenocarcinoma (PC) associated with BRCA mutations: A translational case series. (2012) (12)
A preventive registry for hereditary nonpolyposis colorectal cancer. (1995) (12)
Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines. (1996) (12)
Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy (2016) (12)
Juvenile polyposis syndrome, SMAD4 mutations, and hereditary hemorrhagic telangiectasia. (2012) (12)
Focal chronic pancreatitis mimicking pancreatic head carcinoma: are there suggestive features on ultrasound? (2007) (12)
Overall survival of patients with pancreatic adenocarcinoma and BRCA1 or BRCA2 germline mutation. (2016) (11)
Information Needs of Hepato-Pancreato-Biliary Surgical Oncology Patients (2017) (11)
Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial (2016) (11)
What’s in a name? Tensions between formal and informal communities of practice among regional subspecialty cancer surgeons (2018) (11)
Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer (2020) (11)
Utility of preoperative imaging in evaluating colorectal liver metastases declines over time. (2010) (11)
Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study (2019) (11)
Systematic Review and Meta-Analysis of Prognostic Factors for Early Recurrence in Intrahepatic Cholangiocarcinoma After Curative-Intent Resection (2022) (10)
Platinum-based chemotherapy (Pt-chemo) in pancreatic adenocarcinoma (PC) associated with BRCA mutations: A translational case series. (2012) (10)
Absence of PMS2 mutations in colon‐CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression (2013) (10)
Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy (2020) (10)
Msh 2 deficiency enhances somatic Apc and p 53 mutations in Apc / – Msh 2 – / – mice (2003) (10)
Advances in Brief b-Catenin Mutations Are Specific for Colorectal Carcinomas with Microsatellite Instability but Occur in Endometrial Carcinomas Irrespective of Mutator Pathway 1 (1999) (10)
Integrative molecular profiling and response to chemotherapy on the COMPASS trial. (2019) (9)
Transhepatic embolization of a portohepatic venous fistula. (1996) (9)
Family history of hormonal cancers and colorectal cancer risk: A case‐control study conducted in Ontario (2009) (9)
Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach. (1997) (9)
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In? (2020) (9)
Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario? (2012) (9)
Management of cystic lesions of the tail of the pancreas. (1995) (9)
An integrative DNA sequencing and methylation panel to assess mismatch repair deficiency. (2020) (9)
Planning to avoid trouble in the operating room: experts' formulation of the preoperative plan. (2015) (9)
Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer. (2015) (9)
A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome (2010) (8)
Lynch syndrome in a predominantly Afrocentric population: a clinicopathological and genetic study. (2012) (8)
Impact of Viral Hepatitis on Outcomes after Liver Resection for Hepatocellular Carcinoma: Results from a North American Center (2014) (8)
Effect of PET‐CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long‐term results of a randomized controlled trial (2020) (8)
Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients (2016) (8)
Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells (1999) (8)
Long-term effects of aspirin on colorectal cancer. (2012) (8)
Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinoma (2018) (8)
B7-1 gene transfer into human cancer cells by infection with an adenovirus-B7 (Ad-B7) expression vector (1996) (7)
Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial. (2016) (7)
Simultaneous resection of colorectal cancer with synchronous liver metastases (RESECT), a pilot study (2018) (7)
Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature (2021) (7)
Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong? (2017) (7)
Corrigendum: Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ (2003) (7)
Hereditary nonpolyposis colorectal cancer--molecular basis. (2003) (7)
Comment on: Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. Authors' response (2005) (7)
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution (2020) (6)
Laparoscopic US-guided percutaneous ethanol ablation of hepatocellular carcinoma. (1998) (6)
Peutz-Jeghers Syndrome Diagnosed in a Schizophrenic Patient with a Large Deletion in the STK11 Gene (2006) (6)
Laparoscopic cryosurgery for hepatic tumors. Experimental observations and a case report. (1997) (6)
Comparison of Liver Metastases Volumes on CT, MR and FDG PET Imaging to Pathological Resection Using Deformable Image Registration (2007) (6)
Compartmental analysis of the pharmacokinetics of radioiodinated monoclonal antibody B72.3 in colon cancer patients. (1993) (6)
Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery. (2019) (6)
Management and surveillance of non-functional pancreatic neuroendocrine tumours: Retrospective review. (2019) (6)
Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers (2021) (6)
Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial (2021) (5)
Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns (2016) (5)
The management of metastatic carcinoma in the liver. (1995) (5)
Abstract C57: Organoid profiling identifies common responders to chemotherapy in pancreatic cancer (2019) (5)
Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics. (1993) (5)
Identification of human colon cancer initiating cells (2006) (5)
Surgical treatment of anal incontinence. (1987) (5)
Preliminary results of a phase I study of stereotactic radiotherapy for unresectable primary and metastatic liver cancer (2005) (5)
Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma (2019) (5)
Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model. (1997) (5)
Primary and secondary hepatic malignancies. (1993) (5)
Immunoscintigraphy of human colon cancer xenografts in nude mice using a second‐generation TAG‐72 monoclonal antibody labelled with 99Tcm (1994) (5)
Clinical characterization of hypoxia in pancreatic ductal adenocarcinoma (PDAC) by 18F-FAZA PET and pimonidazole. (2013) (4)
The effect of 5-fluorouracil/leucovorin chemotherapy on CpG methylation, or the confounding role of leukocyte heterogeneity: An illustration. (2015) (4)
Chemosensitivity and clinical characteristics of pancreatic malignancies in BRCA mutation carriers. (2013) (4)
Comparative biodistribution and antibody-dependent cellular cytotoxicity of native and heavy chain chimeric antibody. (1991) (4)
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma (2022) (4)
Chromosome 7q31 allelic imbalance and somatic mutations of RAY1/ST7 gene in colorectal cancer. (2004) (4)
Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers. (2012) (4)
EphB activity suppresses colorectal cancer progression (2005) (4)
Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel (2014) (4)
Screening for pancreatic cancer in a high-risk cohort: A 7-year experience. (2011) (4)
Simulated dose painting of hypoxic sub-volumes in pancreatic cancer stereotactic body radiotherapy (2021) (4)
Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer (2021) (4)
Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study. (2021) (4)
151: Survival following liver resection for metastatic colorectal carcinoma in a large population (2007) (4)
Surgical resection of hepatic and pulmonary metastases from colorectal cancer (2005) (4)
Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types (2019) (4)
Telephone versus in‐person colorectal cancer risk and screening intervention for first‐degree relatives: A randomized controlled trial (2019) (4)
Prognostic factors in resected pancreatic adenocarcinoma: Analysis of 5 year Survivors (2001) (4)
Genotype-phenotype correlations in patients with attenuated adenomatous polyposis coli (1998) (4)
Isolation of human single chain antibodies (scFv) against human TNF-alpha from human peripheral blood lymphocyte-SCID mice. (2002) (4)
Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers (2020) (4)
Advances in the management of pancreatic ductal adenocarcinoma (2021) (4)
Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma. (2019) (4)
Effect of vessel preservation on splenic volume and function in patients with spleen preserving distal pancreatectomies. (2017) (4)
Anatomy, Visualization and Sampling of the Biliary Tree in Animals and Man (1984) (3)
The genomic landscape of recurrent pancreatic cancer is modified by treatment (2020) (3)
Comparison of Practice Guidelines, BRCAPRO, and Genetic Counselor Estimates to Identify Germline BRCA1 and BRCA2 Mutations in Pancreatic Cancer (2018) (3)
Homologous recombination deficiency (HRD) scoring in pancreatic ductal adenocarcinoma (PDAC) and response to chemotherapy. (2020) (3)
Can preoperative liver MRI with gadoxetic acid help reduce open-close laparotomies for curative intent pancreatic cancer surgery? (2021) (3)
Neuroendocrine tumors (NET) of the gastrointestinal tract: A decade of experience at the Princess Margaret Hospital. (2006) (3)
Long-term outcomes of laparoscopic liver resection for hepatocellular carcinoma: A propensity score matched analysis of a high-volume North American center. (2021) (3)
A randomized trial comparing ursodeoxycholic acid and rofecoxib, a selective Cox-2 inhibitor, in the treatment of advanced duodenal adenomas in patients with familial adenomatous polyposis (2001) (3)
GATA6 Expression as a predictor of response to perioperative chemotherapy in resectable pancreatic adenocarcinoma: A multicenter Canadian phase II study (NeoPancONE). (2022) (3)
Survival analysis of PETCAM: A multicenter randomized controlled trial of PET/CT versus no PET/CT for patients with resectable liver colorectal adenocarcinoma metastases. (2012) (3)
SU‐EE‐A3‐04: Deformable Registration for In Vivo Imaging and Pathology Correlation (2006) (3)
Colorectal cancer risk in patients with inflammatory bowel disease and Lynch syndrome (2010) (3)
Erratum: Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ (Nature (2000) 406 (897-902)) (2003) (3)
Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing (2015) (3)
hENT1 gene expression as a predictor of response to gemcitabine and nab-paclitaxel in advanced pancreatic cancer. (2021) (2)
Improving Prognostic Value of CT Deep Radiomic Features in Pancreatic Ductal Adenocarcinoma Using Transfer Learning (2019) (2)
Colorectal Carcinoma Liver Metastasis: Surgical Clinical Perspective (2011) (2)
PET-CT compared to no PET-CT in the management of potentially resectable colorectal cancer liver metastases: The costs implications of a randomized controlled trial. (2016) (2)
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma (2022) (2)
401 – Efficacy and Safety of Combined Cpp-1X/Sulindac Vs Cpp-1X Or Sulindac Alone in Patients with Familial Adenomatous Polyposis: Results from a Double-Blind, Randomized Phase Iii Trial (2019) (2)
956 - Predictors of Splanchnic Vein Thrombosis and Mortality Following Hepatobiliary and Pancreatic Surgery (2018) (2)
hENT1 expression predicts response to gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma (PDAC). (2022) (2)
Liver resection for noncolorectal nonneuro-endocrine hepatic metastases (1998) (2)
A phase II multicenter study of metastasectomy for intra- and extra-hepatic metastases from colorectal cancer. (2013) (2)
Genomics-driven precision medicine for advanced pancreatic ductal carcinoma (PDAC): Early results from the COMPASS trial (NCT02750657). (2018) (2)
Outcomes and Immunogenicity of pancreatic cancer stratified by the HRDetect score. (2020) (2)
Spatially confined sub-tumor microenvironments orchestrate pancreatic cancer pathobiology (2021) (2)
Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma (2022) (2)
Overall survival and clinical characteristics in BRCA mutation carriers with stage I/II pancreatic cancer (PC). (2015) (2)
Abstract 12: Germline BRCA mutations in an unselected cohort of patients with pancreatic adenocarcinoma (2014) (1)
'PREMM 1,2,6 MODEL' as a new gene specific prediction model for Lynch Syndrome: retrospective review of mutation positive cases (2012) (1)
Spontaneous Intestinal Carcinomas and Skin Neoplasms in / Vfs 7 ? 2-deficient Mice 1 (2006) (1)
Abstract 5465: HRDetect as a predictive score of platinum response in advanced PDAC (2020) (1)
Abstract A27: Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma (2016) (1)
Genomic characterization of ATM alterations in advanced pancreatic ductal adenocarcinoma (PDAC). (2021) (1)
Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases. The long-term results of a randomized controlled trial (PET-CT Imaging prior to liver resection for colorectal adenocarcinoma metastases). (2018) (1)
The Proceedings of the Collaborative Group of the Americas on Inherited Colorectal Cancer Sheraton Boston Hotel, Boston, Massachusetts, October 27–29, 2012 (2012) (1)
Familial pancreatic cancer (FPC) status as a clinical biomarker in patients receiving platinum-based systemic therapy: A case-control analysis. (2021) (1)
Gene expression profiling of hepatocellular cancer identifies a consistent pattern in cancerous and distant liver tissue: Arguments for a field defect (2005) (1)
104 Tumor Microenvironment and Genetic Association With Colorectal Cancer Risk (2012) (1)
Characterization of new Ashkenazi Jewish founder mutations in MSH6 causing Lynch syndrome. (2010) (1)
Cytotoxicity of B72.3XOKT3 bispecific antibody recognizing human colon cancer. (1996) (1)
Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer? (2022) (1)
Staging of hepatocellular carcinoma using the clip protocol (2001) (1)
Tumor imaging and pharmacokinetics of 99mTc labelled monoclonal antibody 170H.82 in patients with colorectal cancer (1995) (1)
Corrigendum: EphB receptor activity suppresses colorectal cancer progression (2005) (1)
Canadian Society of Surgical Oncology Meeting (2008) (1)
Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas (2022) (1)
LYMPHOCYTE RESPONSES TO B7 EXPRESSING HUMAN CANCER CELL LINES (1994) (1)
Mo1738 Risk-Benefit Assessment of the Use of Intraperitoneal Drainage After Pancreaticoduodenectomy (2013) (1)
EARLY COLECTOMY AND GENETIC PREDISPOSITION ARE ASSOCIATED WITH THE DEVELOPMENT OF DESMOID TUMORS IN FAMILIAL ADENOMATOUS POLYPOSIS (2006) (1)
Erratum to: Up-front Hepatic Resection for Metastatic Colorectal Cancer Results in Favorable Long-term Survival (2012) (1)
Endoscopic or percutaneous biliary drainage for Klatskin tumors? A large retrospective study. (2012) (1)
Intention to treat analysis of neoadjuvant chemoradiation and liver transplantation for perihilar cholangiocarcinoma. (2016) (1)
Comprehensive genomic analysis of metastatic pancreatic ductal adenocarcinoma (mPDAC) reveals a significant proportion of clinical actionable aberrations. (2019) (1)
Abstract 1282: Genetic basis of hereditary gastric cancer: Beyond the CDH1 locus (2014) (1)
Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies. (2021) (1)
1 DISTINCT MUTATIONAL SIGNATURES ARE ASSOCIATED WITH CORRELATES OF 1 INCREASED IMMUNE ACTIVITY IN PANCREATIC DUCTAL ADENOCARCINOMA 2 3 (2016) (1)
Liver resection for multifocal hepatocellular carcinoma. (2012) (1)
64 Phase I study of stereotactic radiotherapy for unresectable primary and metastatic liver cancer (2006) (1)
Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer. (2022) (1)
Assessment of a 4-chemokine signature in prediction of T-cell inflammation and response to immune checkpoint inhibition across tumor types. (2022) (1)
Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases: The long-term results of a randomized control trial. (2018) (1)
Strategies in the Multidisciplinary Management of Synchronous Colorectal Cancer and Resectable Liver Metastases (2014) (1)
Biliary tract cancer: A large institutional experience. (2012) (1)
Comment on: MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. Authors' reply (2007) (1)
Microsatellite instability and loss of PTEN expression in early versus late-stage endometrial cancer: Results from studies of the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). (2009) (1)
731PPrognosis of familial pancreatic cancer (FPC): A matched case analysis (2017) (1)
Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis. (2022) (1)
Impact of KRAS mutational status on outcomes in patients with pancreatic cancer (PDAC). (2021) (1)
Abstract 35: Novel genetic and clinical determinants of Constitutional Mismatch Repair Deficiency syndrome: Report from the CMMRD consortium (2014) (1)
1072 : Phase I Study Of Stereotactic Radiotherapy for Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma (2006) (1)
MSH 2 2 118 T > C and MSH 6 2 159 C > T promoter polymorphisms and the risk of colorectal cancer (2007) (1)
Sa2045 Tumor Spectrum, Diagnostic Tools and Survival in Patients With Biallelic Mismatch Repair Gene Deficiency (BMMRD) Syndrome: Report From the International BMMRD Consortium (2016) (0)
PD-0035THE CANADIAN COLORECTAL CANCER CONSORTIUM: THE FIRST LARGE-SCALE MOLECULAR BASED APPROACH TO TRANSLATIONAL CANCER CARE IN CANADA (2013) (0)
Abstract 2975: Two putative founder MSH6 mutations associated with inherited cancer susceptibility in Ashkenazi Jewish population (2010) (0)
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution (2020) (0)
Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature (2022) (0)
Whole genome sequencing reveals mechanisms of carcinogenesis in pancreatic ductal adenocarcinoma (2016) (0)
Predictors and outcomes for early recurrence after liver resection for HCC (2005) (0)
Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis (2023) (0)
Mo1742 Clinico-Pathological Features of Solid Pseudopapillary Neoplasms of the Pancreas (2013) (0)
Overall survival and clinical characteristics of BRCA germline/somatic cholangiocarcinoma (CCA). (2016) (0)
The hippurate ratio as an indicator of hepatic reserve in cirrhotics undergoing liver resection (2000) (0)
Abstract 09: Contribution of known and novel BRCA-mediated DNA repair pathway genes to pancreatic cancer susceptibility (2014) (0)
Germline mutations in seemingly sporadic pancreatic cancer. (2017) (0)
Abstract A61: Tandem duplicator phenotype: A potentially targetable genomic subgroup in pancreas cancer (2019) (0)
18th annual meeting: Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC) (2014) (0)
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU) (2022) (0)
63 Primary and adjuvant chemoradiotherapy for locally advanced pancreatic cancer: A phase I/II study with long term outcome (2006) (0)
Abstract 5185: Redefining the somatic landscape of pancreatic adenocarcinoma (2014) (0)
A48 USE OF ENDOSCOPIC ULTRASOUND FINE NEEDLE ASPIRATE AND ENDOSCOPIC ULTRASOUND FINE NEEDLE BIOPSY FOR DETECTION OF GATA6 EXPRESSON IN PANCREATIC DUCTAL ADENOCARINCOMA (2021) (0)
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution (2020) (0)
263 Discordant mismatch repair protein expression in synchronous endometrial and ovarian cancers (2020) (0)
Abstract B036: The role of whole genome duplication in progression of pancreatic ductal adenocarcinoma (2022) (0)
Abstract A9: The pancreatic ductal adenocarcinoma project at the Ontario Institute for Cancer Research. (2012) (0)
Síndromes de cáncer colorrectal hereditario: poliposis adenomatosa familiar y síndrome de Lynch (2008) (0)
Predictive value of 3D computed tomography in assessing hepatic volumes prior to resection (2004) (0)
Abstract A15: Exome sequencing identifies candidate tumor suppressor genes in familial pancreatic cancer. (2012) (0)
Étude de cas CHEMOTHERAPY FOR DESMOID TUMOURS IN ASSOCIATION WITH FAMILIAL ADENOMATOUS POLYPOSIS : A REPORT OF THREE CASES (2013) (0)
Abstract A24: Gene expression along the glycolysis-cholesterol synthesis axis and outcome in pancreatic cancer (2019) (0)
Sclerosing pancreatitis presenting as a periampullary tumour. (2003) (0)
Quality of life in a multicenter phase II trial of metastasectomy for intra- and extra-hepatic metastases from colorectal adenocarcinoma. (2013) (0)
Phase I study of stereotactic radiotherapy for unresectable hepatobiliary cancer and liver metastases (2007) (0)
Abstract A1-17: Genomic analysis of metachronous pancreatic ductal adenocarcinoma (2015) (0)
Potential utility of selective laparoscopy and laparoscopic ultrasound for staging periampullary tumors (2003) (0)
Clinical and molecular profiling of locally advanced compared with metastatic pancreatic adenocarcinoma. (2020) (0)
T2035 Results of Surveillance for Hereditary Pancreatic Cancer Using Annual MRI(CP) (2008) (0)
Use of animal models in colorectal cancer prevention. (2006) (0)
COMPARATIVE PHARMACOKINETICS, RADIOIM-AGING AND BIODISTRIBUTION PROPERTIES OF MONOCLONAL ANTIBODY CC83 LABELLED WITH Tc-99m OR I-123 (1993) (0)
Left renal vein graft for vascular reconstructions: long-term renal outcomes (2016) (0)
Abstract PO-107: Fibroblast differentiation trajectories elicit regional tissue states in pancreatic cancer (2021) (0)
Evaluating Colonoscopy Screening Intervals in Patients with Lynch Syndrome from a Large Canadian Registry. (2023) (0)
1244 INVESTIGATING BLADDER CANCER RISK IN HEREDITARY NON-POLYPOSIS COLORECTAL CANCER PATIENTS WITH MISMATCH REPAIR GENE MUTATIONS (2011) (0)
Whole-genome sequencing of cholangiocarcinoma to reveal distinct profiles of patients with underlying cirrhosis or inflammatory disorders. (2021) (0)
Treatment of Colorectal Cancer (2010) (0)
Prospective genomic/transcriptomic profiling of advanced pancreatic ductal adenocarcinoma (PDAC) for personalized therapy: Feasibility and preliminary results from the COMPASS study (NCT02750657). (2017) (0)
A case series of Lynch syndrome-associated breast cancer. (2014) (0)
Hereditary colorectal cancer. Preface. (2009) (0)
Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring. (2023) (0)
Preliminary evaluation of 18F-FDG-PET/MRI for differentiation of serous from nonserous pancreatic cystic neoplasms: a pilot study (2020) (0)
Partial versus Sleeve Portal Vein Resection in Pancreaticoduodenectomy for Pancreas Cancer: Morbidity Does Not Trump Margins (2012) (0)
Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection. (2023) (0)
A novel pancreatic cancer genetic susceptibility factor (2005) (0)
Predictors of failure following pancreaticoduodenectomy for ampullary carcinoma (2005) (0)
Toronto Management of Initially Unresectable Liver Metastases from Colorectal Cancer in a Living Donor Liver Transplant Program. (2023) (0)
Comparison of guidelines, BRCAPRO, and genetic counsellors estimates for the identification of BRCA1 and BRCA2 mutations in pancreatic cancer. (2017) (0)
Body mass index and risk of colon and rectal cancer stratified by tumor location and sex (2004) (0)
Aberrant crypt foci are rare in the min mouse colon (1995) (0)
Abstract B09: DNA polymerase mutations trigger rapid onset of ultra-hypermutant malignant brain tumors in children with biallelic mismatch repair deficiency (2015) (0)
Comparison of primary and metastatic pancreatic cancer by integration of clinical, pathologic, genomic and transcriptional features (2019) (0)
Additional Syndromes with Hereditary Predisposition to Colorectal Cancer (2009) (0)
Abstract 173: Genomic characterization of patient-derived pancreatic cancer organoids (2023) (0)
Abstract A40: Genomic characterization of locally advanced pancreatic adenocarcinoma (2019) (0)
Genomic characterisation of locally advanced pancreatic adenocarcinoma (2019) (0)
de revue LONG-TERM SURVIVAL AFTER HEPATIC CRYOSURGERY VERSUS SURGICAL RESECTION FOR METASTATIC COLORECTAL CARCINOMA : A CRITICAL REVIEW OF THE LITERATURE (2013) (0)
DNA Damage and Repair Hypoxia Provokes Base Excision Repair Changes and a Repair-De fi cient , Mutator Phenotype in Colorectal Cancer Cells (2014) (0)
A technique for decreasing delayed gastric emptying in the setting of pancreatic fistula (2018) (0)
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
Abstract B031: Loss of GATA6 leads to reduced cell fitness and PDA molecular subtype changes (2022) (0)
Abstract A031: Proteogenomic analysis of the PDAC epithelium reveals tissue markers of subtype identity and biology (2022) (0)
Abstract B28: Epigenetic contribution of Wnt antagonists SFRP1 and DKK1 as prognostic markers in colorectal cancer (2010) (0)
A 4-chemokine signature to predict intermediate immunogenicity in homologous recombination repair deficient tumors. (2021) (0)
The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer (2007) (0)
Abstract A064: High-throughput organoid drug screening to identify molecular vulnerabilities in pancreatic cancer (2022) (0)
Adenocarcinoma of the Pancreas (2020) (0)
Recurrent noncoding regulatory mutations in pancreatic ductal 1 adenocarcinoma 2 3 4 5 6 7 (2017) (0)
PD-0423: Risk group classification for locoregional failure following upfront surgery for pancreatic cancer (2020) (0)
A MODEL TO DESCRIBE THE PHARMACOKINETICS OF I-131 B72.3 MONOCLONAL ANTIBODY IN COLON CANCER PATIENTS (1991) (0)
Abstract B57: Early-onset pancreatic ductal adenocarcinomas are characterized by a distinct mutational landscape (2019) (0)
Abstract 3157: Loss of heterozygosity as a molecular ‘second hit’ In familial pancreatic cancer. (2013) (0)
Effect of portal vein embolization on tumour growth and surgical plan prior to major hepatectomy for hepatocellular carcinoma (2017) (0)
Implications of generating genetic test results for colon cancer in the international, population-based colon cancer family registry. (2012) (0)
476 Germline MYH mutations and risk of colorectal cancer (2004) (0)
Abstracts of presentations to the Annual Meetings of the Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons Canadian Hepato-Pancreato-Biliary Society Canadian Society of Surgical Oncology Canadian Society of Colon and Rectal Surgeons: Victoria, BC Sept. 10-13, 2009. (2009) (0)
Tu1623 Impact of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas After Pancreaticoduodenectomy (2014) (0)
Screening for Lynch syndrome in unselected women with endometrial cancer (2013) (0)
Laparoscopic cryosurgery for hepatic tumors (1997) (0)
Long-term results of concurrent gemcitabine (G) and radiotherapy (GRT) for locally advanced (LA) or high-risk resected (R) pancreatic cancer. (2006) (0)
M1944 Germline Biallelic Mismatch Repair Gene Mutations As a Novel Cause of Intestinal Cancer in Children and Young Adults (2009) (0)
A ten year experience of liver resection combined with major venous reconstruction using hypothermic parenchymal preservation: Is there a learning curve? (2016) (0)
548 Gastrointestinal (GI) Findings in Patients With Biallelic Mismatch Repair (BMMRD) Gene Deficiency Syndrome: Report From the International Consortium (2015) (0)
Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma (2022) (0)
Abstract 4623: Meta-analysis of transcriptomic profiles identifies prognostic model for pancreatic ductal adenocarcinoma patients (2018) (0)
Microbiome-Driven Tryptophan Metabolism Suppresses Immunity in the Pancreatic Tumor Microenvironment by Activation of the Aryl Hydrocarbon Receptor (2021) (0)
Abstract 1485: Tumors with homologous recombination repair deficiency signatures associate with an RNAseq profile profile suggestive of T cell-inflammation (2021) (0)
The value of CT assessment of regional lymph nodes in predicting nodal metastasis, resectability, and survival for periampullary tumors (2005) (0)
12. The University of Toronto HPB Program (2003) (0)
Organoid Personalized Therapeutics and the Pancreatic Adenocarcinoma Signature Stratification for treatment (PASS) – 01 trial (2020) (0)
A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastasis. (2018) (0)
Is Routine Biopsy of Suspicious Liver Lesions Recommended? (2014) (0)
Modifiers of risk in familial adenomatous polyposis (2006) (0)
216 OXALIPLATIN-ASSOCIATED VASCULAR LIVER INJURY IN METASTATIC COLORECTAL CANCER: PATHOLOGIC EXAMINATION LIMITED TO SINUSOIDAL DILATION MISSES THE MAJORITY OF PARENCHYMAL INJURIES (2010) (0)
The clinical approach to a patient with multiple polyps (2008) (0)
1309P CD8+ T cell infiltration is associated with improved survival in advanced pancreatic cancer (2022) (0)
A Truncated hMSH 2 Transcript Occurs as a Common Variant in the Population : Implications for Genetic Diagnosis 1 (2006) (0)
Unifying diagnosis for adenomatous polyps, café-au-lait macules, and a brain mass? (2013) (0)
American Society of Colon and Rectal Surgeons 95th Annual Convention Podium and Poster Abstracts June 9–14, 1996 Seattle, Washington (1996) (0)
Predicting the performance of a genetic testing service for cancer susceptibility. (2007) (0)
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer (2023) (0)
HOSPITAL PROCEDURE VOLUME AND HOSPITAL TEACHING STATUS DO NOT INFLUENCE OPERATIVE MORTALITY OR LONG-TERM SURVIVAL FOR RECTAL CANCER IN A LARGE GENERAL POPULATION: AN OUTCOMES (2006) (0)
MSH2 MUTATIONS AND BLADDER CANCER RISK: FAMILY MEMBERS OF HEREDITARY NONPOLYPOSIS COLORECTAL CANCER (HNPCC) PATIENTS WITH MSH2 MUTATIONS ARE AT INCREASED RISK NOT ONLY FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA (TCC) BUT ALSO BLADDER CANCER (2008) (0)
Abstract 1500: Mediators of CD8+cytotoxic T lymphocyte infiltration in pancreatic cancer (2019) (0)
5 Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study (2020) (0)
Hereditary non-polyposis colorectal cancer (HNPCC): Cancer patterns in germline mutation (hMSH2, hMLH1) positive (M+) and mutation negative (M−) families (1998) (0)
Advances in Brief Polyethylene Glycol 8000 and Colon Carcinogenesis : Inhibition in the F 344 Rat , Promotion in the Min Mouse 1 (2000) (0)
Comparative study of Canadian and Hungarian colon cancer patients (2006) (0)
ASO Visual Abstract: Optimizing Circulating Tumor DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma-Diagnosis, Screening, Minimal Residual Disease Detection, and Treatment Response Monitoring. (2023) (0)
Abstract PO-077: Establishment of a novel living biobank of patient-derived pancreatic cancer organoids with genomic and drug response characterization (2021) (0)
Management and surveillance of non-functional pancreatic neuroendocrine tumors: Retrospective review (2016) (0)
340 Performance characteristics of screening strategies to identify Lynch syndrome in women with non-serous and non-mucinous ovarian cancer (2020) (0)
Radiomics Features Analysis for Tumor Characterization in Pancreatic Ductal Adenocarcinoma (2016) (0)
Abstract 3124: Prognostic biomarkers for pancreatic cancer (2016) (0)
Abstract PR-002: Stromal phenotypic heterogeneity fosters pancreatic cancer progression (2020) (0)
Factors affecting the administration of adjuvant therapy in patients with pancreatic adenocarcinoma. (2013) (0)
Isolation of differentially expressed messenger RNAs from peri-ampullary cancer associated with familial adenomatous polyposis (FAP) (1995) (0)
Abstract 1193: Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials (2021) (0)
Antonija Kreso Response in Colorectal Cancer Variable Clonal Repopulation Dynamics Influence Chemotherapy (2013) (0)
MSH2 MUTATIONS AND BLADDER CANCER RISK: FAMILY MEMBERS OF HEREDITARY NONPOLYPOSIS COLORECTAL CANCER PATIENTS WITH MSH2 MUTATIONS ARE AT INCREASED RISK NOT ONLY FOR UPPER TRACT TRANSITIONAL CELL CARCINOMA BUT ALSO BLADDER CANCER (2008) (0)
The role of preoperative liver biopsy in the diagnosis of hepatocellular carcinoma (2001) (0)
Smoking status and treatment outcome in patients with pancreatic cancer. (2016) (0)
A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy. (2021) (0)
Impact of an inter-professional clinic on pancreatic cancer outcomes: The Princess Margaret Cancer Centre (PM) experience. (2019) (0)
Repair of laparoscopic cholecystectomy bile duct injuries: A ten-year experience at the University of Toronto (2005) (0)
Abstract B91: Primary tumor xenograft establishment from pancreatic resection specimens. (2012) (0)
Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
Intention to treat analysis of neoadjuvant chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma: The toronto experience (2016) (0)
Genetics Of Pancreatic Cancer : What Are The Risks ? Although the risk of pancreatic cancer and ultimate prognosis in asymptomatic mutation carriers (2002) (0)
Practice patterns of medical oncologists: a survey of advance care planning in the outpatient setting (2020) (0)
Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease (2020) (0)
Recurrent hepatocellular carcinoma after radiofrequency ablation or liver resection can be treated with salvage transplantation (2017) (0)
Survival following repeat hepatectomy for metastatic colorectal cancer (2004) (0)
Significance of fundic gland polyp carpeting in familial adenomatous polyposis (2003) (0)
Abstract PO-005: GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials (2020) (0)
Biliary tract cancer; a large institutional experience (2012) (0)
A preclinical trial to evaluate therapies for BRCA-associated pancreatic cancer. (2017) (0)
A retrospective review of the University Health Network (UHN) multimodal treatment experience with extended resection of pancreatic ductal adenocarcinoma (PDAC) in patients with arterial involvement. (2015) (0)
Abstract A036: Plasma extracellular RNA for the detection of pancreatic cancer (2022) (0)
Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma (2023) (0)
Systematic review and meta-analysis of the effect of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis. (2018) (0)
What’s in a name? Tensions between formal and informal communities of practice among regional subspecialty cancer surgeons (2017) (0)
Abstract B31: Establishment and molecular characterization of patient-derived tumor xenografts from resected tumors or ascites fluids of patients with pancreatic/ampullary/bile duct carcinomas (2016) (0)
Impact of neoadjuvant chemotherapy on post-operative outcomes of patients undergoing hepatectomy for intrahepatic cholangiocarcinoma: ACS-NSQIP propensity-matched analysis (2022) (0)
Intestinal Tumorigenesis and Wnt Pathways in Mammary and β Growth Factor-Transcriptional Cooperation between the Transforming (2006) (0)
Integrative analysis of KRAS-wildtype pancreatic ductal adenocarcinoma reveals unique similarities to extrahepatic cholangiocarcinoma. (2022) (0)
Unequal expression of APC alleles in colorectal adenomas of patients with familial adenomatous polyposis (FAP) (1995) (0)
Outcome of adjuvant therapy for biliary tract cancers. (2012) (0)
Information Needs of Hepato-Pancreato-Biliary Surgical Oncology Patients (2016) (0)
Abstract B74: Heterogeneity analysis of hypoxia in surgical samples of pancreatic cancer. (2012) (0)
Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
Major arterial resection for stage 3 adenocarcinoma of the pancreas. (2018) (0)
PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancreatic stump to prevent post-operative pancreatic fistula following distal pancreatectomy. (2021) (0)
Clinicopathologic and genetic features of young patients with colorectal cancer (2010) (0)
Prognostic factors and long-term outcomes of resected pancreatic adenocarcinoma: A comparison between two decades. (2014) (0)
Preoperative serum artemin (ARTN) as a predictive biomarker of recurrence following curative resection for hepatocellular carcinoma (HCC). (2020) (0)
ASO Visual Abstract: Systematic Review and Meta-analysis of Prognostic Factors for Early Recurrence in Intrahepatic Cholangiocarcinoma After Curative-Intent Resection (2022) (0)
Laparoscopic US-Guided Percutaneous Ethanol Ablation of Hepatocellular Carcinoma (1999) (0)
CORRECTION (2007) (0)
The impact of lung and bone metastases on prognosis in advanced PDAC. (2018) (0)
Development of an evidence-based clinical pathway for patients undergoing pancreaticoduodenectomy. (2014) (0)
Abstract B113: Prevalence of germline BRCA and mismatch repair (MMR) gene mutations in pancreatic cancer (2015) (0)
Outcomes and predictors of mortality after liver resection for hepatocellular carcinoma with macrovascular invasion: a cohort study (2018) (0)
Genomic and transcriptomic characterization of advanced pancreatic ductal adenocarcinoma (PDAC) may inform systemic therapy (2017) (0)
Advances in Brief MSH 2 Deficiency Contributes to Accelerated APC-mediated Intestinal Tumorigenesis 1 (2006) (0)
172 INVESTIGATING THE RISK OF BLADDER CANCER AMONG HEREDITARY NON-POLYPOSIS COLORECTAL CANCER (HNPCC) PATIENTS WITH CONFIRMED MISMATCH REPAIR (MMR) GENE MUTATIONS (2011) (0)
Abstract A003: Developmental parallels in pancreatic cancer subtypes revealed by single cell transcriptomics (2022) (0)
2022 Canadian Surgery Forum Sept. 15–17, 2022 (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Steven S. Gallinger?

Steven S. Gallinger is affiliated with the following schools:

Steven S. Gallinger's Academic­Influence.com Rankings

Why Is Steven S. Gallinger Influential?

Steven S. Gallinger's Published Works

Published Works

What Schools Are Affiliated With Steven S. Gallinger?

Steven S. Gallinger's AcademicInfluence.com Rankings